TP53 and acute lymphoblastic leukemia: The most common genetic lesions in T-ALL were NOTCH (58%), Chromatin structure modifiers and epigenetic regulators (58%), and the cell cycle/p53 signaling pathway (58%) (Supplement Fig. S2).